characterize long-term outcomes of single stage AU with a minimum upper range of 100 months of follow. Penile/preputial skin flaps and graft onlay and oral mucosal graft urethroplasties were included. The primary outcome was stricture free survival for one-stage AU. Secondary analysis evaluated differences in outcomes based on two failure definitions: the need for intervention versus presence of recurrent stricture on cystoscopy or urethrography. Hazard rates were induced from the reported failure rates of one-stage AU assuming survival followed an exponential distribution and fixed and random effect models were fitted to the data. A subset analysis removing studies including lichen sclerosus, hypospadias and penile skin graft was also performed.
METHODS: A systematic pubmed and EMBASE review was performed consistent with PRISMA guidelines to characterize long-term outcomes of single stage AU with a minimum upper range of 100 months of follow. Penile/preputial skin flaps and graft onlay and oral mucosal graft urethroplasties were included. The primary outcome was stricture free survival for one-stage AU. Secondary analysis evaluated differences in outcomes based on two failure definitions: the need for intervention versus presence of recurrent stricture on cystoscopy or urethrography. Hazard rates were induced from the reported failure rates of one-stage AU assuming survival followed an exponential distribution and fixed and random effect models were fitted to the data. A subset analysis removing studies including lichen sclerosus, hypospadias and penile skin graft was also performed.
RESULTS: For the meta-analysis, ten studies met inclusion criteria, and two studies reported separate outcomes for grafts and flaps, and were included separately in the analysis. The mean hazard rate across all studies was 0.0044, the corresponding survival rates at 1 year 0.948 (95% CI 0.933-0.964), at 5 years 0.766 (95% CI 0.706-0.831), at 10 years 0.587 (95% CI 0.499-0.691), and at 15 years are 0.45 (95% CI 0.352-0.574). (Figure 1 ). Subset analysis of the 4 select studies noted 1, 5, 10, and 15 year survival rates of 0.97, 0.96, 0.74, and 0.63 respectively.
CONCLUSIONS: The long-term success rates of AU are worse than previously appreciated, with progressive decline in success over time and by quoting intermediate follow up over states and overestimates long term success. Even in the best case scenarios, eliminating lichen sclerosus, hypospadias failures and penile skin graft AU the 15 year success rate was 63%, and thus patients should be counseled accordingly. (N[12) . Several characteristics were compared across treatment groups (penobulbar, isolated penile, and distal). Kaplan-Meier curves were plotted to estimate recurrence-free survival. Patient satisfaction was assessed using a validated outcome measurement tool.
RESULTS: Of 125 patients, 38 (30%), 74 (59%), and 13 (10%) had distal, penile, and penobulbar stricture, respectively. Patients with distal strictures were younger and graft length was shorter compared to those with penile or penobulbar stricture (all P 0.009). The majority of strictures were iatrogenic (38%), followed by hypospadias-related (24%), congenital (17%), traumatic (10%), inflammatory (9%), and post-infectious strictures (2.4%). Of all patients, 47 (38%) had a history of prior urethroplasty. Overall, Qmax improved significantly following surgery (preoperative mean 8.8 vs. postoperative 23.3 ml/s; P<0.001). Median follow-up was 25 months (IQR 7-41) and overall success rate was 70% (88/125 patients). This translated into success rates of 66%, 74%, and 62% for distal, isolated penile, and penobulbar strictures, respectively.
Patients with penile strictures were significantly more satisfied compared to those with distal or penobulbar strictures (84% vs. 61% and 69%, respectively; P[0.035). Reasons for dissatisfaction were recurrence (30%), oral morbidity (11%), erectile dysfunction (11%), urgency (3.7%), pain (3.7%), among others (15%).
CONCLUSIONS: Success rates of Asopa urethroplasty in penile strictures are lower than previously reported. This is most likely due to adverse stricture etiology, complex surgical history, and last resort one-stage surgery in many patients. Thus, preoperative counseling must consider high recurrence risk and staged urethroplasty should be discussed in select cases to optimize patient satisfaction.
Source of Funding: none

MP55-16 COMPREHENSIVE PROSPECTIVE ASSESSMENT OF PATIENT REPORTED OUTCOMES AFTER URETHROPLASTY
Jordan Bekkema*, Keith Rourke, Edmonton, Canada INTRODUCTION AND OBJECTIVES: While urethroplasty is the most effective treatment for urethral stricture, the majority of outcomes are reported from a surgeon perspective and there is limited data describing patient reported outcomes after urethroplasty. Our objective is to comprehensively describe patient reported outcomes after urethroplasty.
METHODS: 357 patients from 2011-2018 were enrolled in a prospective single-center study comprehensively assessing patient reported outcomes after urethroplasty including satisfaction, urinary function, quality of life, erectile function, ejaculatory function, penile appearance/curvature, genitourinary pain, and post-void dribbling. Patient satisfaction was determined using a 5-point Likert scale. Voiding function was assessed with the International Prostate Symptom Score (IPSS). Erectile function was assessment with the International Index of Erectile Function 5 (IIEF-5) and erectile dysfunction was defined as a !5-point change in IIEF-5. Ejaculatory function was scored using a hybrid of the ejaculatory component of the brief sexual function inventory. The remaining measures were assessed using literature derived 3 or 5 point Likert scales. Descriptive statistics were used to summarize findings while both parametric (paired t-test, Chi-square) and non-parametric (Wilcoxon) tests were used to compare pre-and post-operative findings.
RESULTS: Of the 357 patients enrolled, mean age was 49.7 years with a mean stricture length of 4.4cm. Stricture location was most
